Best of Inflammatory Bowel Disease

Best of IBD Collection

• Long-Term Outcomes after Endoscopic Submucosal Dissection for Ulcerative Colitis-Associated Dysplasia
  Matsumoto K. · Oka S. · Tanaka S. · Tanaka H. · Boda K. · Yamashita K. · Sumimoto K. · Ninomiya Y. · Arihiro K. · Shimamoto F. · Chayama K.
  Digestion 2021;102:205–215 (DOI:10.1159/000503341)
• Persistence with Biologic Treatment in Patients with Inflammatory Bowel Disease: A German Claims Data Analysis
  Mevius A. · Brandes A. · Hardtstock F. · Wilke T. · Ratsch B.A. · Orzechowski H.-D. · Fuchs A. · Deiters B. · Bokemeyer B.
  Digestion 2021;102:216–226 (DOI:10.1159/000503859)
• The Correlation between Vitamin D Levels and the Risk of Postoperative Recurrence in Crohn’s Disease
  Yamada A. · Komaki Y. · Komaki F. · Haider H. · Micic D. · Pekow J. · Dalal S. · Cohen R.D. · Cannon L. · Umanskiy K. · Smith R. · Shogan B.D. · Hurst R. · Hyman N. · Rubin D.T. · Sakuraba A.
  Digestion 2021;102:767–775 (DOI:10.1159/000513589)
• Clinical and Radiologic Characteristics of Intra-Abdominal Fistulizing Crohn’s Disease
  Benson A.A. · Aviran E. · Yaari S. · Lev-Cohain N. · Sosna J. · Oren R. · Israeli E.
  Digestion 2020;101:667–673 (DOI:10.1159/000501514)
• Therapeutic Drug Monitoring to Guide Clinical Decision Making in Inflammatory Bowel Disease Patients with Loss of Response to Anti-TNF: A Delphi Technique-Based Consensus
  Greuter T. · Maillard M.H. · Juillerat P. · Michetti P. · Seibold F. · Mottet C. · Zahnd N. · Sauter B. · Schoepfer A.M. · Rogler G. · Vavricka S.R. · on behalf of the Swiss IBDnet, an official working group of the Swiss Society of Gastroenterology
  Digestion 2020;101:683–691 (DOI:10.1159/000501930)
• TNF-Alpha Blockers in Inflammatory Bowel Diseases: Practical Recommendations and a User’s Guide: An Update
  Vulliemoz M. · Brand S. · Juillerat P. · Mottet C. · Ben-Horin S. · Michetti P. · on behalf of Swiss IBDnet, an official working group of the Swiss Society of Gastroenterology
  Digestion 2020;101(suppl 1):16–26 (DOI:10.1159/000506898)
• Emerging Treatment Options in Inflammatory Bowel Disease: Janus Kinases, Stem Cells, and More
  Misselwitz B. · Juillerat P. · Sulz M.C. · Siegmund B. · Brand S. · on behalf of Swiss IBDnet, an official working group of the Swiss Society of Gastroenterology
  Digestion 2020;101(suppl 1):69–82 (DOI:10.1159/000507782)
• Gender Differences in Inflammatory Bowel Disease
  Greuter T. · Manser C. · Pittet V. · Vavricka S.R. · Biedermann L. · on behalf of Swiss IBDnet, an official working group of the Swiss Society of Gastroenterology
  Digestion 2020;101(suppl 1):98–104 (DOI:10.1159/000504701)
• Management of the Elderly Inflammatory Bowel Disease Patient
  Hruz P. · Juillerat P. · Kullak-Ublick G.-A. · Schoepfer A.M. · Mantzaris G.J.e· Rogler G. · on behalf of Swiss IBDnet, an official working group of the Swiss Society of Gastroenterology
  Digestion 2020;101(suppl 1):105–119 (DOI:10.1159/000503099)
• Nutrition in Inflammatory Bowel Disease
  Schreiner P. · Martinho-Grueber M. · Studerus D. · Vavricka S.R. · Tilg H. · Biedermann L. · on behalf of Swiss IBDnet, an official working group of the Swiss Society of Gastroenterology
  Digestion 2020;101(suppl 1):120–135 (DOI:10.1159/000505368)

• Hyposplenism and Gastrointestinal Diseases: Significance and Mechanisms
  Mathur A. · McLean M.H. · Cao H. · Vickers M.A.
  Dig Dis 2022;40:290–298 (DOI:10.1159/000517338)
• Real-Life Comparison of Different Anti-TNF Biologic Therapies for Ulcerative Colitis Treatment: A Retrospective Cohort Study
  Barberio B. · Zingone F. · Frazzoni L. · D’Incà R. · Maccarone M.C. · Ghisa M. · Massimi D. · Lorenzon G. · Savarino E.V.
  Dig Dis 2021;39:16–24 (DOI:10.1159/000508865)
• Crohn’s versus Cancer: Comparison of Functional and Surgical Outcomes after Right-Sided Resections
  Grass F. · Zhu E. · Brunel C. · Hübner M. · Schoepfer A. · Demartines N. · Hahnloser D.
  Dig Dis 2021;39:106–112 (DOI:10.1159/000509748)
• Biomarkers of Inflammation in Inflammatory Bowel Disease: How Long before Abandoning Single-Marker Approaches?
  Dragoni G. · Innocenti T. · Galli A.
  Dig Dis 2021;39:190–203 (DOI:10.1159/000511641)
• Sarcopenia Is a New Risk Factor of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Disease
  Kang M.K. · Kim K.O. · Kim M.C. · Park J.G. · Jang B.I.
  Dig Dis 2020;38:507–514 (DOI:10.1159/000506938)

• Surgical Resection for Crohn’s and Cancer: A Comparison of Disease-Specific Risk Factors and Outcomes
  Larson D.W. · Abd El Aziz M.A. · Perry W. · Behm K.T. · Shawki S. · Mandrekar J. · Mathis K.L. · Grass F.
  Dig Surg 2021;38:120–127 (DOI:10.1159/000511909)

• Early Laparoscopic Ileal Resection for Localized Ileocecal Crohn’s Disease: Hard Sell or a Revolutionary New Norm?
  Maruyama B.Y. · Ma C. · Panaccione R. · Kotze P.G.
  Inflamm Intest Dis 2022;7:13–20 (DOI:10.1159/000515959)
• Proactive versus Reactive Therapeutic Drug Monitoring: Why, When, and How?
  Shmais M. · Regueiro M. · Hashash J.G.
  Inflamm Intest Dis 2022;7:50–58 (DOI:10.1159/000518755)
• Real-World Experience of Endoscopic Submucosal Dissection for Ulcerative Colitis-Associated Neoplasia
  Matsui A. · Hoteya S. · Hayasaka J. · Yamashita S. · Ochiai Y. · Suzuki Y. · Fukuma Y. · Okamura T. · Mitsunaga Y. · Tanaka M. · Nomura K. · Dan N. · Odagiri H. · Kikuchi D.
  Inflamm Intest Dis 2021;6:70–77 (DOI:10.1159/000512292)
• Elevated Faecal Calprotectin in Patients with a Normal Colonoscopy: Does It Matter in Clinical Practice? A Retrospective Observational Study
  Hovstadius H. · Lundgren D. · Karling P.
  Inflamm Intest Dis 2021;6:101–108 (DOI:10.1159/000513473)
• Serum PR3-ANCA Is a Predictor of Primary Nonresponse to Anti-TNF-α Agents in Patients with Ulcerative Colitis
  Yoshida A. · Matsuoka K. · Ueno F. · Morizane T. · Endo Y. · Hibi T.
  Inflamm Intest Dis 2021;6:117–122 (DOI:10.1159/000515361)
• Incidence, Prevalence, and Clinical Epidemiology of Inflammatory Bowel Disease in the Arab World: A Systematic Review and Meta-Analysis
  Mosli M. · Alawadhi S. · Hasan F. · Abou Rached A. · Sanai F. · Danese S.
  Inflamm Intest Dis 2021;6:123–131 (DOI:10.1159/000518003)
• A Novel OGR1 (GPR68) Inhibitor Attenuates Inflammation in Murine Models of Colitis
  de Vallière C. · Bäbler K. · Busenhart P. · Schwarzfischer M. · Maeyashiki C. · Schuler C. · Atrott K. · Lang S. · Spalinger M.R. · Scharl M. · Ruiz-Castro P.A. · Hausmann M. · Rogler G.
  Inflamm Intest Dis 2021;6:140–153 (DOI:10.1159/000517474)
• Validation of a Revised Knowledge Assessment Tool for Children with Inflammatory Bowel Disease (IBD-KID2)
  Vernon-Roberts A. · Otley A. · Frampton C. · Gearry R.B. · Day A.S.
  Inflamm Intest Dis 2020;5:70–77 (DOI:10.1159/000506200)
• Milk Exosomes Prevent Intestinal Inflammation in a Genetic Mouse Model of Ulcerative Colitis: A Pilot Experiment
  Stremmel W. · Weiskirchen R. · Melnik B.C.
  Inflamm Intest Dis 2020;5:117–123 (DOI:10.1159/000507626)
• A Multicentre, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of the S1P Receptor Agonist KRP203 in Patients with Moderately Active Refractory Ulcerative Colitis
  Radeke H.H. · Stein J. · Van Assche G. · Rogler G. · Lakatos P.L. · Muellershausen F. · Moulin P. · Jarvis P. · Colin L. · Gergely P. · Kruis W.
  Inflamm Intest Dis 2020;5:180–190 (DOI:10.1159/000509393)

• How Oral Specialists Can Help Diagnose and Manage Extra-Digestive Inflammatory Bowel Disease Complications
  Thomas C. · Dimmock M. · Gilletta de Saint-Joseph C. · Barres B. · Paul C. · Cousty S. · Laurencin-Dalicieux S.
  Case Rep Gastroenterol 2021;15:276–281 (DOI:10.1159/000513156)
• Cytomegalovirus Enterocolitis in a Patient with Refractory Immune-Related Colitis
  Furuta Y. · Miyamoto H. · Naoe H. · Shimoda M. · Hinokuma Y. · Miyamura T. · Miyashita A. · Fukushima S. · Tanaka M. · Sasaki Y.
  Case Rep Gastroenterol 2020;14:103–109 (DOI:10.1159/000506186)

Connect with Us

Contact Us

If you have any questions, just get in touch with the Editorial Office